Mi, Xinning
Jia, Yunyang
Song, Yanan
Liu, Kaixi
Liu, Taotao
Han, Dengyang
Yang, Ning
Wang, Geng
Guo, Xiangyang
Yuan, Yi
Li, Zhengqian
Article History
Received: 29 June 2023
Accepted: 20 December 2023
First Online: 4 January 2024
Declarations
:
: The study was approved by the Peking University Third Hospital Medical Science Research Ethics Committee (approval No. M2022578) and registered in the Chinese Clinical Trial Registry (ChiCTR2300070569). All participants and their legal guardians will be informed about the study goals. Written informed consent will be obtained from all participants or their legal guardians prior to the study enrollment. The study follows according to the Declaration of Helsinki. Participants as well as their relatives or legal guardians can withdraw consent at any time. All participant information and data will be stored securely and identified by a coded ID number only to maintain participants’ confidentiality.
: Not applicable.
: The authors declare no competing interests.